[go: up one dir, main page]

BRPI0812385A2 - cyclic lactams for the treatment of glaucoma or high intraocular pressure - Google Patents

cyclic lactams for the treatment of glaucoma or high intraocular pressure

Info

Publication number
BRPI0812385A2
BRPI0812385A2 BRPI0812385A BRPI0812385A BRPI0812385A2 BR PI0812385 A2 BRPI0812385 A2 BR PI0812385A2 BR PI0812385 A BRPI0812385 A BR PI0812385A BR PI0812385 A BRPI0812385 A BR PI0812385A BR PI0812385 A2 BRPI0812385 A2 BR PI0812385A2
Authority
BR
Brazil
Prior art keywords
glaucoma
treatment
intraocular pressure
high intraocular
cyclic lactams
Prior art date
Application number
BRPI0812385A
Other languages
Portuguese (pt)
Inventor
W Old David
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0812385A2 publication Critical patent/BRPI0812385A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0812385A 2007-05-23 2008-05-19 cyclic lactams for the treatment of glaucoma or high intraocular pressure BRPI0812385A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93977307P 2007-05-23 2007-05-23
PCT/US2008/064073 WO2008144623A1 (en) 2007-05-23 2008-05-19 Cyclic lactams for the treatment of glaucoma or elevated intraocular pressure

Publications (1)

Publication Number Publication Date
BRPI0812385A2 true BRPI0812385A2 (en) 2019-09-24

Family

ID=39522202

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812385A BRPI0812385A2 (en) 2007-05-23 2008-05-19 cyclic lactams for the treatment of glaucoma or high intraocular pressure

Country Status (13)

Country Link
US (2) US8198315B2 (en)
EP (1) EP2155733B1 (en)
JP (1) JP5524047B2 (en)
AU (1) AU2008254717B2 (en)
BR (1) BRPI0812385A2 (en)
CA (1) CA2688897A1 (en)
CY (1) CY1113448T1 (en)
DK (1) DK2155733T3 (en)
ES (1) ES2395875T3 (en)
PL (1) PL2155733T3 (en)
PT (1) PT2155733E (en)
SI (1) SI2155733T1 (en)
WO (1) WO2008144623A1 (en)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE10838T1 (en) * 1980-02-28 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. 4-SUBSTITUTED 2-OXOAZETIDINE COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND THEIR USE IN ANTIBIOTICS MANUFACTURE.
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US5212176A (en) 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
CN1340051A (en) * 1999-02-11 2002-03-13 辉瑞产品公司 Heteroaryl-substituted quinoline-2-one derivatives useful asticancer agents
KR20030053063A (en) * 2000-11-27 2003-06-27 화이자 프로덕츠 인코포레이티드 Ep4 receptor selective agonists in the treatment of osteoporosis
AU2002358772B2 (en) * 2001-12-20 2008-11-20 Merck Serono Sa Pyrrolidine derivatives as prostaglandin modulators
US7141597B2 (en) 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
NL1026830C2 (en) * 2004-08-12 2006-02-14 Frederik Dirk Petrus Wolf Fishhook.
AU2005313380A1 (en) * 2004-12-06 2006-06-15 Merck Serono Sa Pyrrolidin-2-one derivatives for use as DP1 receptor agonists
US7091231B2 (en) * 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
NZ560691A (en) * 2005-03-10 2011-03-31 Allergan Inc Substituted gamma lactams as therapeutic agents
US7772392B2 (en) * 2005-05-06 2010-08-10 Allergan, Inc. Therapeutic substituted β-lactams
PL2043993T3 (en) * 2006-07-11 2016-02-29 Allergan Inc Cyclopentane derivatives as antiglaucoma agents
DK2160386T3 (en) * 2007-05-23 2012-08-27 Allergan Inc Therapeutic ((phenyl) imidazolyl) methylquinolinyl compounds
WO2009055289A2 (en) * 2007-10-23 2009-04-30 Allergan, Inc. Therapeutic substituted lactams
US7902247B2 (en) * 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
US8063033B2 (en) * 2008-01-18 2011-11-22 Allergan, Inc. Therapeutic beta-lactams

Also Published As

Publication number Publication date
AU2008254717A1 (en) 2008-11-27
JP2010528030A (en) 2010-08-19
DK2155733T3 (en) 2012-10-29
CA2688897A1 (en) 2008-11-23
US20100190823A1 (en) 2010-07-29
EP2155733A1 (en) 2010-02-24
US8198315B2 (en) 2012-06-12
US20100160407A1 (en) 2010-06-24
EP2155733B1 (en) 2012-09-26
SI2155733T1 (en) 2012-12-31
US8383646B2 (en) 2013-02-26
PT2155733E (en) 2013-01-07
ES2395875T3 (en) 2013-02-15
AU2008254717B2 (en) 2014-06-05
WO2008144623A1 (en) 2008-11-27
JP5524047B2 (en) 2014-06-18
PL2155733T3 (en) 2013-02-28
CY1113448T1 (en) 2016-06-22

Similar Documents

Publication Publication Date Title
LTC2137143I2 (en) PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF MICROBIAL DISEASES
HUS1600048I1 (en) Preparation for the treatment of Fabry disease
LT2240137T (en) DEVICE FOR THE TREATMENT OF OBESITY
DK3309139T3 (en) PROCESS FOR THE PREPARATION OF 2,3,3,3-TRIFLUOROPROPENE
BRPI0822625A2 (en) "modular spacer device for the treatment of prosthetic infections"
SMT201600055B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF GLAUCOMA
LT2894165T (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF COMPLEMENT RELATED DISORDERS
BRPI0911577A2 (en) spiroindole derivatives for the treatment of parasitic diseases.
SMP200900085B (en) 3-imidazolyl-indoles for the treatment of malolysiseproliferative.
DK2300443T3 (en) Triazole derivatives useful for the treatment of diseases
IL205671A0 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
HRP20181727T1 (en) USE OF ANTIBODIES AGAINST FACTORS XI, INTENDED FOR THE PREVENTION OR TREATMENT OF BLOOD CONGREGATION
BRPI0716844A2 (en) Useful Kinase Inactors for the Treatment of Proliferative Diseases
BRPI1015006A2 (en) topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
FR2928832B1 (en) WRIST ORTHESIS FOR THE TREATMENT OF CARPENTAL CANAL SYNDROME
DK2148667T3 (en) Use of cyclohexane hexol derivatives for the treatment of eye diseases
BRPI0917440A2 (en) ophthalmic pharmaceutical compositions for the treatment of neoangiogenic eye disorders
DK1868600T3 (en) Spirocyclic cyclohexane derivative for the treatment of drug dependence
IL207397A0 (en) Difluorobiphenylamide derivtives for the treatment of ocular hypertension
BRPI0915428A2 (en) benzoxazinone derivatives acting as beta2 adrenoreceptor agonists for the treatment of respiratory disorders
PT2056804E (en) USE OF 2,5-DIHYDROXYBENZEN DERIVATIVES FOR THE TREATMENT OF EYE DISEASES
DK2117565T3 (en) APPLICATION OF CHITOSANES FOR THE TREATMENT OF NON-FLAMMATORY DISEASES
FI20095600L (en) Composition for the treatment of skin diseases
EP1971589A4 (en) PROCESS FOR THE PREPARATION OF 3-HYDROXYTETRAHYDROFURAN BY CYCLODESHYDRATION
BRPI0912890A2 (en) pharmaceutical composition for the treatment of premature ejaculation

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.